PickEm...alot of what you wrote has gone over my head but I will surely re-read as the whole write up is so focused, intense and interesting.
I would however like to focus on a comment you provided purely from a personal point of view and that was:
"The Moffitt Cancer Centre in the US ran an adaptive therapies metastatic prostate trial which is now complete and being written-up. The released results will not disappoint because the interim results were so spectacular."
Could you elaborate a little more on where to find the results once released as I am vitally/personally interested in any positive cancer (prostate specific) developments. It has been going through my mind for some time that perhaps MPL and its mTOR inhibitor (hopefully that's noted in the right contact) could halt the growth of metastatic prostate cancer?
Really appreciate your time and effort in providing detailed and informative write up
- Forums
- ASX - By Stock
- NUZ
- Paradigm Shift
Paradigm Shift, page-16
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $98.34M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $84.52K | 421.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 49269 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 18063 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 63616 | 0.195 |
7 | 259878 | 0.190 |
11 | 723500 | 0.185 |
6 | 377800 | 0.180 |
5 | 151797 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 2863 | 1 |
0.205 | 126608 | 5 |
0.210 | 172676 | 3 |
0.215 | 154400 | 2 |
0.220 | 140000 | 2 |
Last trade - 14.47pm 15/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online